Home - RegMed XB | Regenerative Medicine Crossing Borders

RegMed XB

Regenerative Medicine Crossing Borders

RegMed XB

News

33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine

33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine

The urgency is high in the field of regenerative medicine. Promising therapies are in the pipeline from the lab to the patient, but a good infrastructure is needed to make this possible.

A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.

A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.

Mohammad Rezaeimoghaddam and Frans van de Vosse have published a paper with the title ”Continuum modeling of thrombus formation and growth under different shear rates” in the Journal of Biomechanics.

The BioLIVE and Pharma IT & Digital Health Expo

The BioLIVE and Pharma IT & Digital Health Expo

Interested in showcasing your BioPharma or Digital Health technologies to the Japanese audience?

Events

RegMed XB Annual Meeting 2022 6 & 7 July, Eindhoven
06-07-2022
Eindhoven

Discover RegMed XB

Copyright © 2021 RegMed XB. All rights reserved
Realisation & design by Joomlapartner